MUFG Americas’s Tvardi Therapeutics TVRD Stock Holding History

MUFG Americas’s Portfolio TVRD Stock Details TVRD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-3	Closed	-$1K	–	1219
2015 Q3	$1K	Buy	+3	New	+$2.01K	﹤0.01%	1151

Other funds holding TVRD

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

RCP

Rho Capital Partners New York $20.4M AUM

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

EAM

EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

RCI

Ridgeback Capital Investments Miami Beach, Florida $560K AUM

CPM

Chesapeake Partners Management Baltimore, Maryland $669M AUM 1.23% 1-Year Est. Return

MUFG Americas's TVRD Position: Q4 2015 in Review

MUFG Americas sold out of Tvardi Therapeutics (TVRD) in Q4 2015, closing a stake of 3 shares — an estimated $1K sold.

MUFG Americas first reported a position in TVRD in Q3 2015 and held it in 1 quarter. The position peaked at $1K in Q3 2015. 95 funds tracked by Wall St. Rank hold TVRD as of Q4 2015.

MUFG Americas reported no remaining Tvardi Therapeutics position as of Q4 2015 after selling out during the quarter.
MUFG Americas sold 3 Tvardi Therapeutics shares in Q4 2015, an estimated $1K.
MUFG Americas first reported a position in Tvardi Therapeutics in Q3 2015 and held it in 1 quarter.
MUFG Americas's Tvardi Therapeutics position peaked at $1K in Q3 2015.
95 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q4 2015.

Based on MUFG Americas's 13F filing for Q4 2015, filed 10 Feb 2016.